Wuxi AppTec Co Ltd Class A 603259
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if 603259 is a good fit for your portfolio.
News
-
WuXi AppTec's Shares Fall After Downbeat Guidance
-
WuXi AppTec's Net Profit Jumps, Reiterates It Doesn't Pose Security Threat
-
WuXi AppTec Revenue Surpassed RMB40 Billion in 2023, and Adjusted Non-IFRS Net Profit Exceeded RMB10 Billion for the First Time
-
WuXi AppTec Says It Left Washington Lobbying Group Voluntarily
-
WuXi Shares Fall as Washington Lobbying Group Cuts Ties
-
WuXi Companies' Shares Fall Amid Renewed U.S. Sanction Concerns
-
WuXi Companies' Shares Rise on Receding Worries About Potential U.S. Sanctions
-
WuXi Advanced Therapies Receives FDA Approval to Manufacture Iovance's AMTAGVI™ (lifileucel) for Advanced Melanoma
Trading Information
- Previous Close Price
- CNY 43.43
- Day Range
- CNY 41.86–42.99
- 52-Week Range
- CNY 41.17–93.56
- Bid/Ask
- CNY 42.23 / CNY 42.24
- Market Cap
- CNY 123.87 Bil
- Volume/Avg
- 56.2 Mil / 96.1 Mil
Key Statistics
- Price/Earnings (Normalized)
- 12.31
- Price/Sales
- 3.19
- Dividend Yield (Trailing)
- 2.06%
- Dividend Yield (Forward)
- 2.06%
- Total Yield
- 2.06%
Company Profile
Wuxi AppTec Co Ltd provides a portfolio of research and manufacturing services through the discovery, development, and manufacturing spectrum for small-molecule drugs, cell therapies, and gene therapies as well as providing testing services for medical devices. Its segments comprise China-based laboratory services; U.S.-based laboratory services; Clinical research and other CRO services; CDMO services; and Others. The majority of revenue gets derived from China-based laboratory services that include small molecules discovery, such as synthetic chemistry, medicinal chemistry, analytical chemistry, biology, drug metabolism and pharmacokinetics (DMPK)/absorption, distribution, metabolism, and excretion (ADME), toxicology and bioanalytical services.
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Stock Style Box
- Large Core
- Total Number of Employees
- 41,116
- Website
- https://www.wuxiapptec.com
Comparables
Valuation
|
Metric
|
603259
|
ACRS
|
300685
|
|---|---|---|---|
Price/Earnings (Normalized) | 12.31 | — | 43.83 |
Price/Book Value | 2.34 | 0.55 | 5.21 |
Price/Sales | 3.19 | 2.75 | 8.61 |
Price/Cash Flow | 9.71 | — | 30.48 |
Price/Earnings
603259
ACRS
300685
Financial Strength
|
Metric
|
603259
|
ACRS
|
300685
|
|---|---|---|---|
Quick Ratio | 1.57 | 3.86 | 13.42 |
Current Ratio | 2.06 | 4.16 | 13.97 |
Interest Coverage | 59.83 | — | 194.63 |
Quick Ratio
603259
ACRS
300685
Profitability
|
Metric
|
603259
|
ACRS
|
300685
|
|---|---|---|---|
Return on Assets (Normalized) | 14.02% | −38.26% | 11.25% |
Return on Equity (Normalized) | 19.29% | −50.08% | 12.34% |
Return on Invested Capital (Normalized) | 16.81% | −49.93% | 12.20% |
Return on Assets
603259
ACRS
300685
Diagnostics & Research Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
TMO
| Thermo Fisher Scientific Inc | Kpqqlcny | Wzrh | $208.9 Bil | |
DHR
| Danaher Corp | Vzrsqfzcf | Ttlwvcr | $175.0 Bil | |
IQV
| IQVIA Holdings Inc | Kdmxhfl | Rnqytv | $41.3 Bil | |
IDXX
| IDEXX Laboratories Inc | Fjkkdsxzw | Zxxmtjp | $39.7 Bil | |
A
| Agilent Technologies Inc | Jpcdxcxzg | Ffdq | $39.4 Bil | |
MTD
| Mettler-Toledo International Inc | Mxvypkzcf | Cnxgk | $25.6 Bil | |
ICLR
| Icon PLC | Zrwjbgt | Fqkqsyl | $24.1 Bil | |
ILMN
| Illumina Inc | Wdjkrmpk | Qpywzc | $18.6 Bil | |
WAT
| Waters Corp | Hrbfqdfhf | Dsj | $18.0 Bil | |
LH
| Laboratory Corp of America Holdings | Vdjftwjs | Drvhdy | $16.8 Bil |